Skip to content

Clinical trials

Idiopathic Pulmonary Fibrosis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Country / region: Taiwan Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20192
20202
20214
20224
20234
20244
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9
Completed7
Active, not recruiting4
Recruiting3
Not yet recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
Bristol-Myers Squibb3
Hoffmann-La Roche2
United Therapeutics2
AbbVie1
Amgen1
AstraZeneca1
Celgene1
Contineum Therapeutics1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis26
Pulmonary Fibrosis8
Lung Diseases, Interstitial6
Idiopathic Interstitial Pneumonias3
Fibrosis1
Lung Diseases1
Pathologic Processes1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.